Ingested (oral) thyrotropin releasing factor (TRH) inhibits EAE

Cytokine

Volumn 61, Issue 1, 2013, Pages 323-328

  Brod, Staley A ^a   Bauer, Victoria ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Adoptive transfer; EAE; Oral proteins; Thyrotropin releasing factor; TRH

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 17; PLACEBO; PROTIRELIN; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; FEMALE; IMMUNOMODULATION; IN VIVO STUDY; LYMPHOCYTE COUNT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN LOCALIZATION; REGULATORY T LYMPHOCYTE; SPLEEN CELL; TH1 CELL; TH17 CELL; UPREGULATION;

ADMINISTRATION, ORAL; ADOPTIVE TRANSFER; ANIMALS; ANTI-INFLAMMATORY AGENTS; CENTRAL NERVOUS SYSTEM; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; INFLAMMATION; INTERLEUKIN-13; INTERLEUKIN-17; MICE; MICE, INBRED C57BL; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; PEPTIDE FRAGMENTS; SPLEEN; TH1 CELLS; TH17 CELLS; THYROTROPIN-RELEASING HORMONE; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 84869865496     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.10.015     Document Type: Article

References (40)

1. Alvord E.C., Shaw C.M., Huby S., Kies M.K. Encephalitogen-induced inhibition of experimental allergic encephalomyelitis: prevention, suppression, and therapy. Ann NY Acad Sci 1965, 122:333-345.
2. Awaad A., Nakamura M., Ishimura K. Imaging of size-dependent uptake and identification of novel pathways in mouse Peyer's patches using fluorescent organosilica particles. Nanomedicine 2011.
3. Bocci V. Is interferon effective after oral administration? The state of the art. J Biol Regul Homeost Agents 1990, 4:81-83.
4. Bocci V. Absorption of cytokines via the oropharyngeal associated lymphoid tissues - does an unorthodox route improve the therapeutic index of interferon. Clin Pharmacokinet 1991, 21:411-417.
5. Brod S.A., Burns D.K. Suppression of relapsing experimental autoimmune encephalomyelitis in the SJL/J mouse by oral administration of type I interferons. Neurology 1994, 44:1144-1148.
6. Brod S.A., Hood Z. Ingested (oral) SIRS peptide 1-21 inhibits acute EAE by inducing Th(2)-like cytokines. J Neuroimmunol 2007, 183:89-95.
7. Brod S.A., Hood Z.M. Ingested (oral) alpha-MSH inhibits acute EAE. J Neuroimmunol 2008, 193:106-112.
8. Brod S.A., Hood Z.M. Ingested (oral) ACTH inhibits EAE. J Neuroimmunol 2011, 232:131-135.
9. Brod S.A., Hood Z.M. Ingested (oral) SST inhibits EAE. Autoimmunity 2011, 44:437-443.
10. Brod S.A., Khan M. Oral administration of IFN-alpha is superior to subcutaneous administration of IFN-alpha in the suppression of chronic relapsing experimental autoimmune encephalomyelitis. J Autoimmun 1996, 9:11-20.
11. Brod S.A., Khan M., Kerman R.H., Pappolla M. Oral administration of human or murine interferon alpha suppresses relapses and modifies adoptive transfer in experimental autoimmune encephalomyelitis. J Neuroimmunol 1995, 58:61-69.
12. Chiba Y., Shida K., Nagata S., Wada M., Bian L., Wang C., et al. Well-controlled proinflammatory cytokine responses of Peyer's patch cells to probiotic Lactobacillus casei. Immunology 2010, 130:352-362.
13. Dong C. Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells. Nat Rev Immunol 2006, 6:329-333.
14. Eantuzzi L., Eid P., Malorni W., Rainaldi G., Gauzzi M., Pellegrini S., et al. Post-translational up-regulation of the cell surface-associated alpha component of the human type I interferon receptor during differentiation of peripheral blood monocytes: role in the biological response to type I interferon. Eur J Immunol 1997, 27:1075-1081.
15. Feuer C., Prentice D.E., Cammisuli S. Chronic relapsing experimental allergic encephalomyelitis in the lewis rat. J Neuroimmunol 1985, 10:159-166.
16. Gaffen S.L., Kramer J.M., Yu J.J., Shen F. The IL-17 cytokine family. Vitam Horm 2006, 74:255-282.
17. Haddad E.E., Mashaly M.M. Effect of thyrotropin-releasing hormone, triiodothyronine, and chicken growth hormone on plasma concentrations of thyroxine, triiodothyronine, growth hormone, and growth of lymphoid organs and leukocyte populations in immature male chickens. Poult Sci 1990, 69:1094-1102.
18. Harbour D.V., Kruger T.E., Coppenhaver D., Smith E.M., Meyer W.J. Differential expression and regulation of thyrotropin (TSH) in T cell lines. Mol Cell Endocrinol 1989, 64:229-241.
19. Hart R., Wagner F., Steffens W., Lersch C., Dancygier H., Duntas L., et al. Effect of thyrotropin-releasing hormone on immune functions of peripheral blood mononuclear cells. Regul Pept 1990, 27:335-342.
20. Issazadeh S., Mustafa M., Ljungdahl A., Hojeberg B., Dagerlind A., Elde R., et al. Interferon gamma, interleukin 4 and transforming growth factor beta in experimental autoimmune encephalomyelitis in Lewis rats: dynamics of cellular mRNA expression in the central nervous system and lymphoid cells. J Neurosci Res 1995, 40:579-590.
21. Kamath J., Yarbrough G.G., Prange A.J., Winokur A. The thyrotropin-releasing hormone (TRH)-immune system homeostatic hypothesis. Pharmacol Ther 2009, 121:20-28.
22. Kruger T.E., Smith L.R., Harbour D.V., Blalock J.E. Thyrotropin: an endogenous regulator of the in vitro immune response. J Immunol 1989, 142:744-747.
23. Lersch C., Hammer C., Krombach F., Dancygier H. Effect of thyrotropin-releasing hormone (TRH) on the chemiluminescence (CL) activity of human mononuclear cells. J Clin Lab Immunol 1989, 28:69-71.
24. Malefyt R., Haanen J., Spits H., Roncarolo M.-G., te Velde A., Figdor C., et al. IL-10 and viral IL-10 strongly reduce antigen specific human T cell proliferation by diminishing the antigen presenting capacity of monocytes via downregulation of class II MHC expression. J Exp Med 1991, 174:915-924.
25. Mellado M., Fernandez-Agullo T., Rodriguez-Frade J.M., San Frutos M.G., de la Pena P., Martinez A.C., et al. Expression analysis of the thyrotropin-releasing hormone receptor (TRHR) in the immune system using agonist anti-TRHR monoclonal antibodies. FEBS Lett 1999, 451:308-314.
26. Monney L., Sabatos C.A., Gaglia J.L., Ryu A., Waldner H., Chernova T., et al. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 2002, 415:536-541.
27. Murphy A.C., Lalor S.J., Lynch M.A., Mills K.H. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis. Brain Behav Immun 2010, 24:641-651.
28. Offner H., Subramanian S., Wang C., Afentoulis M., Vandenbark A.A., Huan J., et al. Treatment of passive experimental autoimmune encephalomyelitis in SJL mice with a recombinant TCR ligand induces IL-13 and prevents axonal injury. J Immunol 2005, 175:4103-4111.
29. Perez Castro C., Penalva R., Paez Pereda M., Renner U., Reul J.M., Stalla G.K., et al. Early activation of thyrotropin-releasing-hormone and prolactin plays a critical role during a T cell-dependent immune response. Endocrinology 1999, 140:690-697.
30. Raiden S., Polack E., Nahmod V., Labeur M., Holsboer F., Arzt E. TRH receptor on immune cells: in vitro and in vivo stimulation of human lymphocyte and rat splenocyte DNA synthesis by TRH. J Clin Immunol 1995, 15:242-249.
31. Raine C.S., Stone S.H. Animal models for multiple sclerosis: chronic experimental allergic encephalomyelitis in inbred guinea pigs. NY State J Med 1977, 77:1693-1696.
32. Renno T., Krakowski M., Piccirillo C., Lin L., Owens T. TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines. J Immunol 1995, 154:944-953.
33. Rollwagen R., Baqar S. Oral cytokine administration. Immunol Today 1996, 17:548-550.
34. Shreedhar V.K., Kelsall B.L., Neutra M.R. Cholera toxin induces migration of dendritic cells from the subepithelial dome region to T- and B-cell areas of Peyer's patches. Infect Immun 2003, 71:504-509.
35. Soni J., Baird A.W., O'Brien L.M., McElroy M., Callanan J.J., Bassett H.F., et al. Rat, ovine and bovine Peyer's patches mounted in horizontal diffusion chambers display sampling function. J Control Release 2006, 115:68-77.
36. Tompkins S.M., Padilla J., Dal Canto M.C., Ting J.P., Van Kaer L., Miller S.D. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis. J Immunol 2002, 168:4173-4183.
37. Wang J., Klein J.R. Hormone regulation of murine T cells: potent tissue-specific immunosuppressive effects of thyroxine targeted to gut T cells. Int Immunol 1996, 8:231-235.
38. Wang J., Whetsell M., Klein J.R. Local hormone networks and intestinal T cell homeostasis. Science 1997, 275:1937-1939.
39. Wisnewski H.M., Keith A.B. Chronic relapsing experimental allergic encephalomyelitis: an experimental model of multiple sclerosis. Ann Neurol 1977, 1:144-148.
40. ser. J Interferon Res 1992, 12:411-413.